Insider Transactions in Q1 2022 at Cerevel Therapeutics Holdings, Inc. (CERE)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 31
2022
|
Pf Equity Holdings 1 B.V. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
27,349,211
-100.0%
|
-
|
Mar 29
2022
|
John Renger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-83.47%
|
$350,000
$35.0 P/Share
|
Mar 29
2022
|
John Renger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+45.5%
|
$30,000
$3.5 P/Share
|
Mar 18
2022
|
John Renger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,000
-90.99%
|
$640,000
$32.5 P/Share
|
Mar 18
2022
|
John Renger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+47.64%
|
$60,000
$3.5 P/Share
|
Mar 16
2022
|
John Renger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-92.66%
|
$750,000
$30.0 P/Share
|
Mar 16
2022
|
John Renger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+48.1%
|
$75,000
$3.5 P/Share
|
Mar 09
2022
|
John Renger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
30,000
-73.01%
|
$990,000
$33.75 P/Share
|
Mar 09
2022
|
John Renger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+48.4%
|
$90,000
$3.5 P/Share
|
Mar 02
2022
|
John Renger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-92.66%
|
$750,000
$30.0 P/Share
|
Mar 02
2022
|
John Renger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+48.1%
|
$75,000
$3.5 P/Share
|
Feb 09
2022
|
John Renger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-92.66%
|
$750,000
$30.0 P/Share
|
Feb 09
2022
|
John Renger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+48.1%
|
$75,000
$3.5 P/Share
|
Jan 04
2022
|
Norbert G Riedel |
BUY
Exercise of conversion of derivative security
|
Direct |
14,270
+25.0%
|
-
|